mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.1 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.1 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |